Cocrystal Pharma COCP
NASDAQ COCP
$1.16 +0.02 (+1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Cocrystal Pharma's Return on Capital Employed [ROCE] was -295.48% in Q2 2026, down 131.36 percentage points from -164.12% a year earlier and down 152.99 percentage points from the prior quarter.

Analysis

Cocrystal Pharma (COCP) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Cocrystal Pharma came in at -96.21%, down 6.51 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of -72.26 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -89.71% in FY2024 (-33.10 pp), -56.60% in FY2023 (+9.32 pp), -65.92% in FY2022 (-44.14 pp) and -21.79% in FY2021 (+2.16 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2011.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in two of the last eight quarters, with an average year-over-year change of -50.04 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2021 (a gain of 112.40 percentage points); the worst was Q2 2026 (a drop of 131.36 percentage points).
  • Per Business Quant data, COCP's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -142.49% (Q1 2026), -114.61% (Q4 2025) and -122.78% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Cocrystal Pharma 16.00 Mn -5.91 Mn - -295.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -295.48%
Mar 31, 2026 -142.49%
Dec 31, 2025 -114.61%
Sep 30, 2025 -122.78%
Jun 30, 2025 -164.12%
Mar 31, 2025 -158.60%
Dec 31, 2024 -143.99%
Sep 30, 2024 -113.91%
Jun 30, 2024 -87.43%
Mar 31, 2024 -66.38%
Dec 31, 2023 -64.72%
Sep 30, 2023 -56.56%
Jun 30, 2023 -55.38%
Mar 31, 2023 -109.78%
Dec 31, 2022 -92.39%
Sep 30, 2022 -80.24%
Jun 30, 2022 -59.43%
Mar 31, 2022 -20.69%
Dec 31, 2021 -17.90%
Sep 30, 2021 -14.31%
API Access

Cocrystal Pharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=COCP&period=max&api_key=YOUR_API_KEY